Australia said on Thursday it planned to become the fourth country in the world to legalise medicinal marijuana exports in a bid to score a piece of the estimated $55 billion global market.
Tag Archives: Cann Group
VANCOUVER, Aug. 31, 2017 /Weed Wire/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update.
At a secret location in Australia’s southeast, Peter Crock delicately tends to a two-month-old cannabis cutting. Barely knee high, it is one of about 50 government-sanctioned “mother plants” to be cloned for future generations of crops for the country’s fledgling medicinal marijuana industry.
On May 30, 2017, Cann Group Limited, an Australian medical cannabis company, announced that it had obtained the permits required to start cultivating medical cannabis and should begin its cultivation operation in the next few days.
VANCOUVER, March 28, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that it has committed to taking part in the initial public offering (“IPO”) of Cann Group Limited (“Cann Group”) on the Australian Stock Exchange (“ASX”) as the cornerstone investor.
CANBERRA, Australia, March 8, 2017 /Weed Wire/ — Today the Office of Drug control issued the second licence under the medicinal cannabis provisions of the Narcotic Drugs Act 1967. This is the first commercial medicinal cannabis licence and authorises the cultivation and production of Australian grown cannabis into the manufacture chain and for subsequent therapeutic supply to Australian patients.